Principal Investigator
Joshua Hare
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230568
Clinical Trial Summary
A phase 2, adaptive, double-blinded, placebo controlled, randomized, multi-center trial to evaluate the efficacy, safety and tolerability of intracoronary infusion of AB-1002 in adult subjects with New York Heart Association (NYHA) Class III heart failure and non-ischemic cardiomyopathy.
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Russell Saltzman
Phone Number
+1 (305) 243-1152
Email
r.saltzman@umiami.edu